Related Experiment Video
Updated: Aug 14, 2026

06:49
Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model
Published on: April 7, 2023
Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
Efstratios M Kolibianakis1, Evangelos G Papanikolaou, Michel Camus
1Unit for Human Reproduction, Aristotle University, Thessaloniki, Greece. Stratis.Kolibianakis@otenet.gr
Human Reproduction (Oxford, England)
|December 13, 2005
Summary
The time from menstruation to hCG administration impacts IVF success. A longer menstruation-free interval is associated with a lower chance of ongoing pregnancy in women undergoing IVF.
Area of Science:
- Reproductive Endocrinology
- In Vitro Fertilization (IVF)
Background:
- The menstruation-free interval (MFI) is a factor in IVF outcomes.
- Understanding MFI's impact is crucial for optimizing treatment protocols.
Purpose of the Study:
- To prospectively assess the association between MFI and ongoing pregnancy rates in IVF patients.
- To determine if MFI predicts IVF success.
Main Methods:
- 90 patients received recombinant FSH (rFSH) and GnRH antagonist.
- Oocyte maturation was triggered with hCG when three follicles ≥17 mm were observed.
- Single embryo transfer was performed in 64.6% of eligible patients.
Main Results:
- The ongoing pregnancy rate per embryo transfer was 18.3%.
- The MFI significantly predicted ongoing pregnancy probability (OR 0.70; 95% CI: 0.54-0.92).
- Logistic regression controlled for female age and LH levels.
Conclusions:
- A longer MFI correlates with a reduced likelihood of ongoing pregnancy in IVF.
- This finding is relevant for patients stimulated with rFSH and GnRH antagonist.
Related Concept Videos
Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
In Vitro Fertilization
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Meiosis II
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...